The proportional decrease in prostate specific antigen level best predicts the duration of survival after hormonal therapy in patients with metastatic carcinoma of the prostate

Christopher P Evans, V. Gajendran, A. Tewari, K. Aslam, R. Juster, S. Gange, A. Eason, P. Narayan

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint Dive into the research topics of 'The proportional decrease in prostate specific antigen level best predicts the duration of survival after hormonal therapy in patients with metastatic carcinoma of the prostate'. Together they form a unique fingerprint.

Medicine & Life Sciences